These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 5504551)
21. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease]. Gomirato G; Perfetti C Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838 [No Abstract] [Full Text] [Related]
22. Management of Parkinson's disease with L-dopa therapy. Tyler E Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360 [No Abstract] [Full Text] [Related]
23. [Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease]. Ferrari M; Furlanut M; Battistin L; Benedetti A; Mingrino S Clin Ter; 1971 May; 57(4):351-6. PubMed ID: 5110949 [No Abstract] [Full Text] [Related]
27. [Therapy of Parkinson's disease with L-dopa. Preliminary considerations on 40 cases]. Rigotti S; Angelini C; Battistin L; Denes F Riv Sper Freniatr Med Leg Alien Ment; 1970 Dec; 94(6):1516-26. PubMed ID: 5518765 [No Abstract] [Full Text] [Related]
28. Parkinson's disease. Recent advances in treatment. Barbeau A N Y State J Med; 1970 Oct; 70(19):2437-43. PubMed ID: 5271788 [No Abstract] [Full Text] [Related]
29. L-dopa and the patient with Parkinson's disease. Fangman A; O'Malley WE Am J Nurs; 1969 Jul; 69(7):1455-7. PubMed ID: 5192672 [No Abstract] [Full Text] [Related]
31. [Recent advances in the therapy of Parkinson's syndrome]. Lombardo L Gac Med Mex; 1974 Jun; 107(6):513-24. PubMed ID: 4448355 [No Abstract] [Full Text] [Related]
32. [Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease]. Uriciuoli R; Nivoli GC Minerva Med; 1968 May; 59(43):2516-21. PubMed ID: 5664430 [No Abstract] [Full Text] [Related]
33. [Effect of L-DOPA on the akinesis in Parkinson's syndrome]. Bischoff A Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650 [No Abstract] [Full Text] [Related]
34. The effect of L-dopa treatment on the speech of patients with Parkinson's disease. Audelman JU; Hoel RL; Lassman FM Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064 [No Abstract] [Full Text] [Related]
35. Changes in saccadic eye movements of patients with Parkinson's disease before and after L-dopa. Highstein S; Cohen B; Mones R Trans Am Neurol Assoc; 1969; 94():277-9. PubMed ID: 5374461 [No Abstract] [Full Text] [Related]
36. [Biochemistry and treatment of Parkinson's disease]. Barbeau A Laval Med; 1970 Sep; 41(7):902-5. PubMed ID: 5509487 [No Abstract] [Full Text] [Related]
37. [Levo-dopa in the treatment of Parkinson's disease]. Fasano VA; Urciuoli R; Broggi G; Cannella M Minerva Med; 1969 Nov; 60(95):4733-45. PubMed ID: 5357313 [No Abstract] [Full Text] [Related]
38. [Parkinson's syndrome. 1. Biochemistry of the monoamines]. Roos BE Lakartidningen; 1970 Oct; 67(42):4803-6. PubMed ID: 5483442 [No Abstract] [Full Text] [Related]